About:
Multiple Myeloma Plasma - Cryopreserved human plasma collected from clinically confirmed multiple myeloma donors. Multiple Myeloma plasma is ideal for understanding changes in cytokines and circulating tumor DNA (ctDNA).
IRB-approved
Worldwide shipping
Full donor metadata
No medications, Cyclophosphamide, Mesna, Dexamethasone
1
$667.00
78664
Multiple Myeloma
1.0 ML
58
Male
No medications, Cyclophosphamide, Lomustine, Melphalan
1
$667.00
78759
Multiple Myeloma
1.0 ML
58
Male
No medications, Cyclophosphamide, Mesna, Dexamethasone
1
$667.00
78665
Multiple Myeloma
1.0 ML
58
Male
No medications, Cyclophosphamide, Lomustine, Melphalan
1
$667.00
78666
Multiple Myeloma
1.0 ML
58
Male
No medications, Cyclophosphamide, Lomustine, Melphalan
1
$667.00
78760
Multiple Myeloma
1.0 ML
58
Male
No medications, Cyclophosphamide, Mesna, Dexamethasone
1
$667.00
75952
Multiple Myeloma
1.0 ML
Hispanic/Latino
69
Female
20
$667.00
75950
Multiple Myeloma
1.0 ML
Hispanic/Latino
56
Female
21
$667.00
75949
Multiple Myeloma
1.0 ML
Hispanic/Latino
68
Female
24
$667.00
Multiple Myeloma Plasma | High-Quality Human Plasma from Multiple Myeloma Donors
Multiple Myeloma Plasma is collected from donors clinically diagnosed with multiple myeloma and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on biomarker discovery in multiple myeloma pathophysiology.
Product Features
Research Use Only (RUO)
Plasma collected from clinically confirmed multiple myeloma donors
Processed within one day of collection
IRB-approved protocols and informed consent
Custom aliquot volumes available upon request
De-identified Donor Data
Verified multiple myeloma diagnosis
Demographic data: age, sex assigned at birth, race/ethnicity
Donor-reported medications, allergies, and comorbidities
Additional multiple myeloma-specific metadata available
Applications
Biomarker discovery and validation
Cytokine and inflammation profiling
Metabolomics and proteomics studies
Therapeutic response research
Compliance and Quality Assurance
IRB-approved and HIPAA-compliant protocols
Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
Documentation support available for regulatory review
Ordering and Customization
Multiple Myeloma plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
What is the turnaround time for custom/prospective collections?
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
Do you have samples in stock?
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
What does unique donor mean?
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
Do you guarantee unique donors?
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
Are samples collected under IRB-approved protocols?
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.